The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors
Minhang Xin(Zhejiang University), Xinge Zhao(Simcere Pharmaceutical (China)), Han Shen(The University of Sydney), Chongxing Tu(Simcere Pharmaceutical (China)), Feng Tang(Simcere Pharmaceutical (China)), Jun Wen(Simcere Pharmaceutical (China))
Cited by 31
Related Papers
Small molecule selenium-containing compounds: Recent development and therapeutic applications
|European Journal of Medicinal Chemistry|2021|233
Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y
|European Journal of Medicinal Chemistry|2019|192
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review
|European Journal of Medicinal Chemistry|2018|168
Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)
|European Journal of Medicinal Chemistry|2020|120
Strategies to target the Hedgehog signaling pathway for cancer therapy
|Medicinal Research Reviews|2018|108